锂盐药物在1970年获得美国食品药品管理局（FDA）最初批准时，还被认为可能导致服药的母亲生下心脏瓣膜缺损的婴儿，而且所谓的比例还非常高（约为1/50）。

When it was first approved by the FDA in 1970, lithium was believed to cause heart-valve defects in an extremely high percentage of infants born to mothers who were on the drug (about 1 in 50).

youdao

锂盐药物在1970年获得美国食品药品管理局（FDA）最初批准时，还被认为可能导致服药的母亲生下心脏瓣膜缺损的婴儿，而且所谓的比例还非常高（约为1/50）。

When it was first approved by the FDA in 1970, lithium was believed to cause heart-valve defects in an extremely high percentage of infants born to mothers who were on the drug (about 1 in 50).

youdao